Welcome to
Allurion’s
Newsroom

Filter by language : AR / EN / ES / FR / IT
March 31, 2017

Allurion Repays Massachusetts Life Sciences Center

MLSC – The Massachusetts Life Sciences Center (MLSC) and Natick-based Allurion Technologies announced that the company, which was awarded a $750,000 Accelerator loan from the MLSC in 2011, has repaid the loan with interest after a successful funding round from private investors.

March 1, 2017

VIDEO – Blue Mirror – Interview with Allurion co-founder Samuel Levy

START-UP FOOD

February 7, 2017

More Data on Balloon-in-a-Pill Show Almost 15% Weight Loss

MEDSCAPE – Results from another small trial with a novel intragastric balloon that can be swallowed without the patient requiring endoscopy or anesthesia show that the 42 participants lost an average of 15.6 kg (34 lb), or over 14% of their body weight, over the 16-week duration of the trial.

The patients involved in the study had an average BMI of 38.6 kg/mat the start of the study and in this case were put on a ketogenic, very low-calorie diet (700 kcal/day) diet for the last 4 weeks of the trial.

February 7, 2017

Number To Know…10

MEDTECH INSIGHT – 10 minutes is the time it takes to prep the non-surgical, ingestible Elipse gastric balloon for obesity treatment. Elipse is developed by Allurion Technologies, which just bagged $19m in new funding.

January 4, 2017

21 intriguing new ideas and trailblazing people

BOSTON GLOBE – Free college for Boston students, an Alzheimer’s hope, weight loss in an (inflatable) pill, and more.

October 27, 2016

Lyfebulb and Novo Nordisk A/S announce the ten patient entrepreneur finalists for the Lyfebulb-Novo Nordisk Innovation Award

GLOBE NEWSWIRE – The Award Recognizes Patient Entrepreneurs’ Innovative Efforts and Ideas for Management of Diabetes Using Consumer Products, Medical Devices, or Healthcare Information Technologies

May 17, 2016

Allurion offers gastric bypass surgery in a pill

TECHCRUNCH – Just swallow a pill and it expands into a balloon in your stomach so you don’t feel hungry. No gastric bypass, no surgery required. Sounds magical, but Boston-based Allurion has created the only non-invasive gastric balloon for obesity.

May 17, 2016

Expanding in Stomachs and in Europe, Allurion Adds $6M for Anti-Obesity Device

XCONOMY BOSTON – Plenty of companies sell pills for weight loss or obesity treatment. None of them are quite like Allurion Technologies.

May 5, 2016

Allurion Technologies’ Elipse™ Gastric Balloon Receives European Marketing Approval

MARKET WIRED – World’s First Procedureless Weight Loss Device Offers a New Treatment Option for Overweight and Obese Individuals

December 8, 2015

Allurion Technologies’ Elipse™ Intragastric Balloon Receives Prestigious SAGES Innovation Award

BUSINESS WIRE – Allurion Technologies announced today that its flagship product, Elipse, has received the prestigious Emerging Technology Innovation Award from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).